BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

PhysioSonics to Optimize Cerebral Blood Flow Monitor for Military Use


11/3/2011 11:53:06 AM

BELLEVUE, Wash., Nov. 3, 2011 /PRNewswire/ -- PhysioSonics announced today that it received a $2.5 million grant from the Telemedicine and Advanced Technology Research Center. TATRC is an organization within the headquarters of the U.S. Army Medical Research and Materiel Command, located at Fort Detric, Maryland. With this grant, PhysioSonics will optimize its proprietary cerebral blood-flow monitor to detect vasospasm. Following a successful launch in the civilian healthcare market, the military will test the blood-flow monitor with the goal of deploying it at military facilities that care for soldiers with traumatic brain injuries (TBI).

Blast-induced TBI is a common occurrence on the battlefield, and can be among the most devastating and difficult to detect. Vasospasm refers to a condition in which the blood vessels shudder, leading to vasoconstriction, or shrinkage of the vessels, causing reduced blood flow within the brain. This can result in brain damage or even death. Vasospasm occurs in nearly half of blast-induced TBI victims. The ability to monitor soldiers at high risk for vasospasm can lead to potentially life-saving, preventative treatments. Monitoring their treatment for vasospasm, once it occurs, can also reduce morbidity and mortality. Vasospasm is difficult to detect and monitor with currently available technology.

"PhysioSonics has developed a simple to use, portable monitor that can automatically identify the mid-cerebral artery and provide a continuous read of the blood's flow and peak velocity," said Brad Harlow, CEO of PhysioSonics. "This is essential for diagnosing and monitoring vasospasm. Transcranial Doppler ultrasound the current technology standard relies on highly trained medical personnel and is therefore too awkward and expensive to be deployed near combat, or even at high volume military hospitals. We believe that our blood flow monitor, adapted for the rigors of military use, can help clinicians accurately monitor for vasospasm among soldiers injured by a blast, from an improvised explosive device, a land mine, or another traumatic explosion."

Use of PhysioSonics' cerebral blood flow device for detecting vasospasm is investigational and not an approved use in the United States. The company recently completed a clinical study of its blood flow monitor that showed parity with transcranial Doppler ultrasound. It intends to file a 510k application for the blood-flow monitor with the U.S. Food and Drug Administration.

Upon commercialization, the company intends to sell the device and disposables to hospitals with neurosurgery and cardiac surgery suites in the U.S. It will later submit a pre-market approval application to the FDA to add a non-invasive intracranial pressure monitoring indication to the device.

About PhysioSonics

PhysioSonics has developed a user-independent, non-invasive, long-term cerebral blood flow (CBF) and emboli monitor. Utilizing novel ultrasound technology, the company has developed a new method that enables the device to automatically locate and hold on the cerebral artery without a trained sonographer. This auto-locating ultrasound technology thus enables an easy-to-use method for the continuous monitoring of CBF and emboli.

Company Contact: Brad Harlow, 425-732-2814
Media Contact: Steve DiMattia, 917-620-0590

SOURCE PhysioSonics



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->